126 related articles for article (PubMed ID: 33653596)
21. Circulating miR-31-5p may be a potential diagnostic biomarker in nasopharyngeal carcinoma.
Yi SJ; Liu P; Chen BL; Ou-Yang L; Xiong WM; Su JP
Neoplasma; 2019 Sep; 66(5):825-829. PubMed ID: 31129965
[TBL] [Abstract][Full Text] [Related]
22. A Panel of Tumor-associated Autoantibodies for the Detection of Early-stage Breast Cancer.
Hong CQ; Weng XF; Huang XC; Chu LY; Wei LF; Lin YW; Chen LY; Liu CT; Xu YW; Peng YH
J Cancer; 2021; 12(9):2747-2755. PubMed ID: 33854634
[TBL] [Abstract][Full Text] [Related]
23. Systematic comparison of plasma EBV DNA, anti-EBV antibodies and miRNA levels for early detection and prognosis of nasopharyngeal carcinoma.
Tan LP; Tan GW; Sivanesan VM; Goh SL; Ng XJ; Lim CS; Kim WR; Mohidin TBBM; Mohd Dali NS; Ong SH; Wong CY; Sawali H; Yap YY; Hassan F; Pua KC; Koay CE; Ng CC; Khoo AS;
Int J Cancer; 2020 Apr; 146(8):2336-2347. PubMed ID: 31469434
[TBL] [Abstract][Full Text] [Related]
24. Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan.
Coghill AE; Pfeiffer RM; Proietti C; Hsu WL; Chien YC; Lekieffre L; Krause L; Teng A; Pablo J; Yu KJ; Lou PJ; Wang CP; Liu Z; Chen CJ; Middeldorp J; Mulvenna J; Bethony J; Hildesheim A; Doolan DL
Clin Cancer Res; 2018 Mar; 24(6):1305-1314. PubMed ID: 29301829
[No Abstract] [Full Text] [Related]
25. Exosomal cyclophilin A as a novel noninvasive biomarker for Epstein-Barr virus associated nasopharyngeal carcinoma.
Liu L; Zuo L; Yang J; Xin S; Zhang J; Zhou J; Li G; Tang J; Lu J
Cancer Med; 2019 Jun; 8(6):3142-3151. PubMed ID: 31063269
[TBL] [Abstract][Full Text] [Related]
26. Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis.
Tang ZM; Ling ZG; Wang CM; Wu YB; Kong JL
PLoS One; 2017; 12(7):e0182117. PubMed ID: 28750095
[TBL] [Abstract][Full Text] [Related]
27. Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance.
Fu X; Shen C; Wang H; Chen F; Li G; Wen Z
BMC Cancer; 2017 Jul; 17(1):479. PubMed ID: 28693532
[TBL] [Abstract][Full Text] [Related]
28. Distinguishing early-stage nasopharyngeal carcinoma from benign hyperplasia using intravoxel incoherent motion diffusion-weighted MRI.
Ai QY; King AD; Chan JSM; Chen W; Chan KCA; Woo JKS; Zee BCY; Chan ATC; Poon DMC; Ma BBY; Hui EP; Ahuja AT; Vlantis AC; Yuan J
Eur Radiol; 2019 Oct; 29(10):5627-5634. PubMed ID: 30903340
[TBL] [Abstract][Full Text] [Related]
29. Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma.
King AD; Woo JKS; Ai QY; Chan JSM; Lam WKJ; Tse IOL; Bhatia KS; Zee BCY; Hui EP; Ma BBY; Chiu RWK; van Hasselt AC; Chan ATC; Lo YMD; Chan KCA
Ann Oncol; 2019 Jun; 30(6):977-982. PubMed ID: 30912815
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of p62 Induces Autophagy and Promotes Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells through Promoting ERK Signaling Pathway.
Wu Q; Xiang M; Wang K; Chen Z; Long L; Tao Y; Liang Y; Yan Y; Xiao Z; Qiu S; Yi B
Curr Cancer Drug Targets; 2020; 20(8):624-637. PubMed ID: 32329689
[TBL] [Abstract][Full Text] [Related]
31. Serum proteomic-based analysis identifying autoantibodies against PRDX2 and PRDX3 as potential diagnostic biomarkers in nasopharyngeal carcinoma.
Lin LH; Xu YW; Huang LS; Hong CQ; Zhai TT; Liao LD; Lin WJ; Xu LY; Zhang K; Li EM; Peng YH
Clin Proteomics; 2017; 14():6. PubMed ID: 28184180
[TBL] [Abstract][Full Text] [Related]
32. Serum and urine metabolomics analyses reveal metabolic pathways and biomarkers in relation to nasopharyngeal carcinoma.
Liao Z; Zhao L; Zhong F; Zhou Y; Lu T; Liu L; Gong X; Li J; Rao J
Rapid Commun Mass Spectrom; 2023 Mar; 37(6):e9469. PubMed ID: 36593223
[TBL] [Abstract][Full Text] [Related]
33. DNA Methylation Biomarkers for Nasopharyngeal Carcinoma: Diagnostic and Prognostic Tools.
Jiang W; Cai R; Chen QQ
Asian Pac J Cancer Prev; 2015; 16(18):8059-65. PubMed ID: 26745039
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic values of serum cathepsin B and D in patients with nasopharyngeal carcinoma.
Tan G; Liu Q; Tang X; Kang T; Li Y; Lu J; Zhao X; Tang F
BMC Cancer; 2016 Mar; 16():241. PubMed ID: 26995190
[TBL] [Abstract][Full Text] [Related]
35. Pretreatment age and serum lactate dehydrogenase as predictors of synchronous second primary cancer in patients with nasopharyngeal carcinoma.
Yeh CF; Ho CY; Chin YC; Shu CH; Chao YT; Lan MY
Oral Oncol; 2020 Nov; 110():104990. PubMed ID: 32932171
[TBL] [Abstract][Full Text] [Related]
36. Detection of methylation status of Epstein-Barr virus DNA C promoter in the diagnosis of nasopharyngeal carcinoma.
Zheng XH; Wang RZ; Li XZ; Zhou T; Zhang JB; Zhang PF; Lu LX; Jia WH
Cancer Sci; 2020 Feb; 111(2):592-600. PubMed ID: 31834989
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of serum autoantibody levels in the diagnosis of ovarian endometrioma.
Yi YC; Wang SC; Chao CC; Su CL; Lee YL; Chen LY
J Clin Lab Anal; 2010; 24(5):357-62. PubMed ID: 20872572
[TBL] [Abstract][Full Text] [Related]
38. Protein tyrosine kinase 6 is associated with nasopharyngeal carcinoma poor prognosis and metastasis.
Liu LN; Huang PY; Lin ZR; Hu LJ; Liang JZ; Li MZ; Tang LQ; Zeng MS; Zhong Q; Zeng BH
J Transl Med; 2013 Jun; 11():140. PubMed ID: 23758975
[TBL] [Abstract][Full Text] [Related]
39. Autoantibodies as potential biomarkers for nasopharyngeal carcinoma.
Tong YQ; Zhang ZJ; Liu B; Huang J; Liu H; Liu Y; Guo FJ; Zhou GH; Xie PL; Li YH; Zuo CH; Hu JY; Li GC
Proteomics; 2008 Aug; 8(15):3185-93. PubMed ID: 18654982
[TBL] [Abstract][Full Text] [Related]
40. Cytoplasmic p27 is a novel prognostic biomarker and oncogenic protein for nasopharyngeal carcinoma.
Teng Y; Hu L; Yu B; Li X; Chen M; Fu X; Zhang J; Gao Y; Xu R; Zhu J
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):336-344. PubMed ID: 31884829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
